Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03722784 · ClinicalTrials.gov registry record · NA
Evaluation of Silicone Hydrogel Daily Wear Contact Lenses for Up to One (1) Month of Daily Wear
A NA study, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
NCT03722784 is a NA study that has completed, run by CooperVision. The registered enrollment target is 88 participants.
The verdict
NCT03722784, a NA study, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
Study Summary
The aim of the study is to evaluate if the performance of Invigor A is substantially equivalent to Invigor B contact lenses when used in a one month recommended replacement, daily wear modality.
Interventions
- DEVICE Invigor A (test)
- DEVICE Invigor B (control)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2018-10-10 |
| Est. Completion | 2019-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03722784
The ClinicalTrials.gov registry entry for NCT03722784 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Invigor A (test) is the first listed.
NCT03722784 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03722784 about?
NCT03722784 is a clinical study titled "Evaluation of Silicone Hydrogel Daily Wear Contact Lenses for Up to One (1) Month of Daily Wear". The aim of the study is to evaluate if the performance of Invigor A is substantially equivalent to Invigor B contact lenses when used in a one month recommended replacement, daily wear modality.
What is the current status of trial NCT03722784?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2018-10-10. Estimated completion is 2019-06-01.
What interventions are being tested in trial NCT03722784?
The interventions under investigation include: Invigor A (test) (DEVICE), Invigor B (control) (DEVICE).
Who is sponsoring clinical trial NCT03722784?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.